2013
DOI: 10.1016/j.nicl.2013.07.006
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging

Abstract: The Alzheimer's Disease Neuroimaging Initiative (ADNI) recently added diffusion tensor imaging (DTI), among several other new imaging modalities, in an effort to identify sensitive biomarkers of Alzheimer's disease (AD). While anatomical MRI is the main structural neuroimaging method used in most AD studies and clinical trials, DTI is sensitive to microscopic white matter (WM) changes not detectable with standard MRI, offering additional markers of neurodegeneration. Prior DTI studies of AD report lower fracti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

35
282
5
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 300 publications
(324 citation statements)
references
References 108 publications
35
282
5
2
Order By: Relevance
“…It was not clear whether the increased axial diffusivity that we observed in GW veterans with predicted GB/GF exposure relative to unexposed veterans was associated with neurodegeneration or white matter reorganization because increased axial diffusivity has been linked with both (e.g., amyotrophic lateral sclerosis (Metwalli et al, 2010), Alzheimer's disease (Bosch et al, 2010;Nir et al, 2013;Shu et al, 2011), animal models of Parkinson disease (Hikishima et al, 2015), white matter reorganization due to axonal recovery or even regrowth (Sidaros et al, 2008;Voss et al, 2006)). For this reason, we conducted post hoc analyses to examine the association between DTI measures and neurobehavioral performance.…”
Section: Va Author Manuscriptmentioning
confidence: 93%
See 1 more Smart Citation
“…It was not clear whether the increased axial diffusivity that we observed in GW veterans with predicted GB/GF exposure relative to unexposed veterans was associated with neurodegeneration or white matter reorganization because increased axial diffusivity has been linked with both (e.g., amyotrophic lateral sclerosis (Metwalli et al, 2010), Alzheimer's disease (Bosch et al, 2010;Nir et al, 2013;Shu et al, 2011), animal models of Parkinson disease (Hikishima et al, 2015), white matter reorganization due to axonal recovery or even regrowth (Sidaros et al, 2008;Voss et al, 2006)). For this reason, we conducted post hoc analyses to examine the association between DTI measures and neurobehavioral performance.…”
Section: Va Author Manuscriptmentioning
confidence: 93%
“…VA Author Manuscript VA Author Manuscript Nir et al, 2013;Sullivan et al, 2010). This was our rationale for examining other DTI parameters in GW veterans with and without predicted GB/GF exposure in the present study.…”
Section: Va Author Manuscriptmentioning
confidence: 99%
“…Some of these studies also demonstrated strong correlation with widely-used clinical measures [20,23,24].…”
Section: Introductionmentioning
confidence: 83%
“…Prior DTI studies in sporadic AD have reported lower FA and increased MD, RD, and/or AxD, throughout WM, mainly in the corpus callosum, fornix, cingulum, superior longitudinal fasciculus, and inferior longitudinal fasciculus [19][20][21][22]. Some of these studies also demonstrated strong correlation with widely-used clinical measures [20,23,24].…”
Section: Introductionmentioning
confidence: 91%
“…A more sensitive to microscope WM changes technique is diffusion tension imaging (DTI). Nir et al (2013) showed widespread diffusivity disruptions associated with neuropsychological and cognitive deficits in specific tracts that passed through the temporal lobe and posterior brain regions in AD and MCI patients 10 . Despite MRI is widely used for AD, the accuracy of MRI as biomarker of early AD generally reaches an accuracy of 80% 11 , what encourages the search of better biomarkers and more accurate diagnostic tools.…”
Section: Challenges In the Discovery Of Potential Biomarkers In Alzhementioning
confidence: 95%